New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List ...Middle East

PR Newswire - News
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List
ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the new...

Read More Details
Finally We wish PressBee provided you with enough information of ( New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List )

Apple Storegoogle play

Also on site :

Most viewed in News